Robert A. Forbes
Impact in
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Attention Deficit Hyperactivity Disorder
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Schizophrenia research and treatment 24
- Bipolar Disorder and Treatment 13
- Electroconvulsive Therapy Studies 6
- Pharmacology 13
- Treatment of Major Depression 12
- Co-authors
- Huasheng Lu (1 shared paper)Ajay Verma (1 shared paper)Robert D. McQuade (16 shared papers)Elizabeth Murphy (2 shared papers)Charles Steenbergen (1 shared paper)William H. Carson (14 shared papers)Tetsuro Kikuchi (6 shared papers)Yoshihiro Tadori (5 shared papers)
- Journals
- European Journal of Pharmacology (5 papers)Journal of Child and Adolescent Psychopharmacology (4 papers)Schizophrenia Research (4 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)The Journal of Clinical Psychiatry (2 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Robert A. Forbes
51 papers receiving 2.4k citations
Robert A. Forbes's Hit Papers
Peers
Comparison fields: 5 of 128
- Psychiatry and Mental health 999
- Cancer Research 461
- Developmental Neuroscience 111
- Biological Psychiatry 47
- Pathology and Forensic Medicine 287
Countries citing papers authored by Robert A. Forbes
This map shows the geographic impact of Robert A. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Forbes more than expected).
Fields of papers citing papers by Robert A. Forbes
This network shows the impact of papers produced by Robert A. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Forbes. The network helps show where Robert A. Forbes may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis Hit paper breakdown → | 2002 | 691 |
| 2 | 2001 | 317 | |
| 3 | 2008 | 194 | |
| 4 | 2012 | 167 | |
| 5 | 2001 | 157 | |
| 6 | 2009 | 140 | |
| 7 | 2013 | 76 | |
| 8 | 2008 | 58 | |
| 9 | 2011 | 57 | |
| 10 | 2008 | 50 | |
| 11 | 2013 | 48 | |
| 12 | 2007 | 48 | |
| 13 | 2011 | 46 | |
| 14 | 2010 | 34 | |
| 15 | 2009 | 32 | |
| 16 | 2013 | 27 | |
| 17 | 2013 | 25 | |
| 18 | 1996 | 23 | |
| 19 | 2011 | 22 | |
| 20 | 2013 | 21 |
About Robert A. Forbes
Robert A. Forbes is a scholar working on Psychiatry and Mental health, Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience, having authored 51 papers that have together received 2.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (24 papers), Bipolar Disorder and Treatment (13 papers), Treatment of Major Depression (12 papers), Pharmaceutical studies and practices (7 papers), Electroconvulsive Therapy Studies (6 papers), Adolescent and Pediatric Healthcare (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Psychiatry and Mental health (999 citations), Cancer Research (461 citations), Developmental Neuroscience (111 citations), Biological Psychiatry (47 citations) and Pathology and Forensic Medicine (287 citations). Robert A. Forbes has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Huasheng Lu, Ajay Verma, Robert D. McQuade, Elizabeth Murphy, Charles Steenbergen, William H. Carson, Tetsuro Kikuchi, Yoshihiro Tadori, Na Jin and Gregory A. Stephenson. Their work appears in journals such as European Journal of Pharmacology, Journal of Child and Adolescent Psychopharmacology, Schizophrenia Research, Journal of Pharmaceutical and Biomedical Analysis and The Journal of Clinical Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.